Rhabdoid tumor predisposition syndrome 2: genes and variants

Explore variant evidence for Rhabdoid tumor predisposition syndrome 2 across 2 analyzed proteins (SMARCA4, SMARCB1). Linked ClinVar records include 10 pathogenic or likely pathogenic variants, 1,563 variants of uncertain significance and 144 with conflicting classifications.

Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.

Data updated 2026-11-05. Automated aggregation, not a clinical review date.

Download variant evidence (CSV)

Genes linked to Rhabdoid tumor predisposition syndrome 2

ClinVar pathogenic and likely pathogenic variants linked to Rhabdoid tumor predisposition syndrome 2

VariantPositionProtein partClinical label
SMARCA4 R1203C1203Helicase C-terminalPathogenic / likely pathogenic (★★)
SMARCA4 Y732H732Pathogenic / likely pathogenic (★)
SMARCA4 Y732F732Pathogenic / likely pathogenic (★)
SMARCA4 R1157W1157Helicase C-terminalPathogenic / likely pathogenic (★)
SMARCA4 G719D719RNA-binding region which is sufficient for bindiPathogenic / likely pathogenic (★)
SMARCA4 K755E755Pathogenic / likely pathogenic (★)
SMARCA4 L768P768Helicase ATP-bindingPathogenic / likely pathogenic (★)
SMARCA4 G784W784Helicase ATP-bindingPathogenic / likely pathogenic (★)
SMARCA4 G951A951Pathogenic / likely pathogenic (★)
SMARCA4 T1032N1032Pathogenic / likely pathogenic (★)

Which prediction tools work for Rhabdoid tumor predisposition syndrome 2

Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.

Diseases related to Rhabdoid tumor predisposition syndrome 2

Frequently asked questions

Which genes have records linked to Rhabdoid tumor predisposition syndrome 2?

This view contains 2 analyzed proteins: SMARCA4, SMARCB1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.

What do the clinical classifications mean?

Linked records include 10 pathogenic or likely pathogenic variants, 1,563 variants of uncertain significance and 144 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.

Does the evidence score change a VUS classification?

No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.

Can I download the variant evidence?

Download the CSV for all 1,776 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.

About this data

Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.

Download every variant as CSV · Browse all diseases · Methods · About the Center